Medicamentos de actualidad. Drugs of today

New product intros [ezetimibe/pitavastatin (new combination), ozoralizumab, ripasudil/brimonidine (new combination), spesolimab, valemetostat tosylate (first-in-class), valoctocogene roxaparvovec]

Pub Date : 2023-01-01 DOI: 10.1358/dot.2023.59.1.3544242

Pamiparib for germline BRCA mutation-associated recurrent advanced ovarian, fallopian tube or primary peritoneal cancer.

Pub Date : 2022-06-01 DOI: 10.1358/dot.2022.58.6.3389001 Anna Skrzypczyk-Ostaszewicz

Bimekizumab for psoriasis.

Pub Date : 2022-06-01 DOI: 10.1358/dot.2022.58.6.3400572 M. Rodrigues, Egídio Freitas, T. Torres